Using the same congenitally helpless rats, Padilla et al. (2011) found that a protective effect of fluoxetine correlated with changes in regional CCO activity in a variety of brain networks, including the IPN; this indicates that increased IPN metabolic activity was correlated with depression. The gene discussed is RYR1; the disease is depressive disorder.